SCHEMBL3572819

SCHEMBL3572819

CCOC(=O)C(Cc1ccc2c(c1)OCO2)C(=O)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.49
MEN1 O00255 2/20 0.49
USP2 O75604 1/20 0.49
ALDH1A1 P00352 1/20 0.49
LMNA P02545 1/20 0.49
MAPT P10636 1/20 0.49
ALOX15 P16050 1/20 0.49
HSD17B10 Q99714 1/20 0.49
CYP3A4 P08684 2/20 0.49
TSHR P16473 1/20 0.47
TRPM8 Q7Z2W7 1/20 0.46
HPGD P15428 2/20 0.45
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
HTT P42858 1/20 0.45
CTNNB1 P35222 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7574108 0.88 CYP3A4 (0.56) KMT2AMEN1USP2ALDH1A1LMNA
SCHEMBL6157430 0.88 CYP3A4 (0.58) KMT2AMEN1USP2ALDH1A1LMNA
SCHEMBL7699367 0.84 CYP3A4 (0.58) KMT2AMEN1USP2ALDH1A1LMNA
SCHEMBL6250712 0.79 MDM2 (0.69) KMT2AMEN1ALDH1A1LMNAMAPT
SCHEMBL8248139 0.78 CYP3A4 (0.59) KMT2AMEN1USP2ALDH1A1LMNA
SCHEMBL11732644 0.78 CYP3A4 (0.56) KMT2AMEN1USP2ALDH1A1LMNA
SCHEMBL9263319 0.78 CYP3A4 (0.59) KMT2AMEN1USP2ALDH1A1LMNA
SCHEMBL9381254 0.77 MAPT (0.46) KMT2AMEN1USP2ALDH1A1LMNA
SCHEMBL12439954 0.77 CYP3A4 (0.52) KMT2AMEN1USP2ALDH1A1LMNA
Hydrochloric Acid SCHEMBL8497507 0.77 CYP3A4 (0.58) KMT2AMEN1USP2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7741323-B2 Indene derivatives and process for the preparation thereof KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2010-06-22 US disclosed
US-20070185109-A1 Idene derivatives and process for the preparation thereof KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2007-08-09 US disclosed
EP-1740531-A1 INDENE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF Korea Research Institute of Chemical Technology (KR) 2007-01-10 EP disclosed
WO-2005100303-A1 INDENE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2005-10-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185109-A1 Idene derivatives and process for the preparation thereof INSR, PPARD, GPR119 KMT2A 3388/4885MEN1 2055/4885USP2 4401/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.